Hemodialysis and Peritoneal Dialysis Market – Growth of Market Size, Market Dynamics, Trends, Segments and Forecast Period (2024-2030)

  • The Hemodialysis and Peritoneal Dialysis Market Size is valued at 93.70 Billion in 2023 and is expected to reach 154.45 Billion by the year 2030 at a 7.4% CAGR during the forecast period for 2024 -2030.

  • Format : PDF | Report ID : SMR_1536

Hemodialysis and Peritoneal Dialysis Market Overview

Numerous reasons, such as the rising incidence of diabetes, the chronic kidney disease (CKD) prevalence, and the expanding demand for home-based dialysis, are fuelling the market's expansion. End-stage kidney disease (ESKD), which calls for dialysis or a kidney transplant, is greatly increased by CKD. The most popular kind of dialysis, hemodialysis, is thought to make up more than 90% of the global dialysis market. But peritoneal dialysis is gaining popularity because it has a number of benefits over hemodialysis, including more independence and flexibility. As CKD and ESKD prevalence rises, it is anticipated that the hemodialysis and peritoneal dialysis market would expand over the future years.

 

Additionally, the creation of cutting-edge dialysis equipment and products is anticipated to contribute to the market's continued expansion. The most popular form of dialysis, with over 88% of the global market in 2022, is hemodialysis. It includes passing the blood through a dialyzer to filter out waste materials and extra fluid. Three times a week for a few hours each, hemodialysis is normally carried out in a dialysis facility. The peritoneum, the lining of the abdomen, is used to filter blood during peritoneal dialysis. The abdomen is given a dialysis solution, which draws wastes and extra fluid from the blood and absorbs them.

 

Hemodialysis and Peritoneal Dialysis Market

 

To get more Insights: Request Free Sample Report

 

Hemodialysis and Peritoneal Dialysis Market Dynamics: Drivers, Opportunities, Challenges and Restraints

Chronic kidney disease (CKD) is becoming more common, and it poses a serious risk for developing end-stage renal disease (ESRD), which calls for dialysis. Worldwide, the prevalence of CKD is rising as a result of ageing, diabetes, and hypertension. Acute kidney injury (AKI) is a quick reduction in kidney function that can cause end-stage renal disease (ESRD). AKI is becoming more common everywhere as a result of things like infection, trauma, and surgery. Kidney transplantation is the chosen treatment for ESRD, however there is a shortage of organs available for transplant. The number of patients receiving dialysis has increased as a result of this. Patients now have access to more effective and convenient dialysis thanks to technological developments in dialysis equipment and other items. As a result, more people are choosing to have dialysis treatment.

 

Governments all over the world are taking steps to support ESRD sufferers and enhance access to dialysis treatment. The market for hemodialysis and peritoneal dialysis is expanding as a result of this. Due to the increased convenience and flexibility it provides patients, home dialysis is growing in popularity. The need for additional products, such as home dialysis equipment, is being driven by this. Peritoneal dialysis is becoming more widely known One type of dialysis that can be done at home is peritoneal dialysis. Although it is less intrusive than hemodialysis, not all patients are candidates. The demand for peritoneal dialysis, however, is rising as a result of more public awareness of the procedure. Patients now have more access to dialysis therapy thanks to the rise in the number of dialysis facilities around the world. In several countries, reimbursement policies for dialysis therapy are improving, which is also fuelling the market's expansion.

 

Hemodialysis and Peritoneal Dialysis Market Opportunities

ESRD, which necessitates dialysis or kidney transplantation, is on the rise in incidence due to chronic kidney disease (CKD), which is a key risk factor. Worldwide, the prevalence of CKD is rising as a result of conditions like diabetes, hypertension, and obesity. As the world's population ages, older people are more likely to develop CKD and ESRD. More patient-friendly, effective, and efficient dialysis systems are being created. With these developments, more patients can now obtain and afford dialysis. As it gives patients more freedom and control over their care, home dialysis is gaining popularity. In the upcoming years, the market for home dialysis is anticipated to expand more quickly than the dialysis market as a whole.

 

The prevalence of CKD and ESRD is increasing quickly in emerging countries including China, India, and Brazil. Due to this, there is a substantial demand for dialysis goods and services in these countries. Implantable artificial kidneys and wearable dialysis equipment are also currently being developed. These innovations could completely alter how dialysis is provided in the future.

 

Hemodialysis and Peritoneal Dialysis Market Challenges

Dialysis is expensive for patients as well as healthcare systems. Some patients may find this to be a barrier to care, particularly in low- and middle-income nations. Dialysis treatment necessitates the services of qualified healthcare experts, such as nephrologists, dialysis nurses, and technicians. These specialists are in short supply, which may restrict the future availability of dialysis care. Dialysis facilities are few in some areas. Patients may find it challenging to receive the care they require as a result. In addition to kidney illness, many patients also have diabetes and hypertension. These coexisting conditions can complicate dialysis treatment and raise the possibility of complications. Dialysis patients are more likely to have an infection. Patients may find this to be a significant worry and be discouraged from obtaining therapy. Dialysis product manufacture is subject to strict regulatory regulations.

 

This may hinder innovation and make it harder for new businesses to enter the market. To increase the cost and accessibility of dialysis, governments and healthcare systems can collaborate. This could entail boosting the availability of qualified healthcare workers, extending access to dialysis centres, and offering patient subsidies. Companies that create and produce dialysis goods can endeavour to lower treatment costs and create innovative, safer, and more efficient solutions. Clinicians can strive to provide dialysis patients with better care while lowering the risk of complications. This can entail creating novel treatment regimens, improving patient education and support, and collaborating with other medical specialists to handle patients' comorbidities.

 

Hemodialysis and Peritoneal Dialysis Market Restraints

Hemodialysis and peritoneal dialysis both carry potential hazards and side effects, such as infection, bleeding, and cardiovascular issues. For older patients and those with many comorbidities, these risks can be quite substantial. Dialysis is an extremely expensive form of care, and costs are only predicted to rise in the near future. As a result, many patients, particularly those in developing nations, may find it more difficult to pay dialysis. There is an international lack of qualified healthcare workers with dialysis experience. The availability of dialysis treatment may be restricted in various regions of the world due to this shortage. Dialysis and its advantages are not well known in some poor nations. This may cause patients to put off getting dialysis until their condition worsens, which could make treatment more challenging and expensive.

 

Market participants are attempting to overcome these obstacles by creating new and enhanced dialysis technology, lowering the cost of care, and raising knowledge of the procedure. For instance, some businesses are working on wearable dialysis equipment that would enable patients to get dialysis at home. New dialysis membranes that are more effective and less prone to have issues are being developed by other businesses.

 

Hemodialysis and Peritoneal Dialysis Market Trends

Globally rising incidences of end-stage renal disease (ESRD) and chronic kidney disease (CKD). Growing rates of diabetes and hypertension, two of the main factors contributing to CKD and ESRD. The ageing population, as CKD and ESRD are more common in older persons. The rising popularity of home dialysis, which offers patients greater convenience and flexibility than in-center dialysis. Improvements in dialysis equipment and supplies technology. Home dialysis is becoming more and more common because it gives patients more convenience and flexibility. About 15% of all dialysis procedures in the United States in 2023 were performed at home. As more patients choose home dialysis over in-center dialysis, this share is anticipated to increase during the ensuing years. One type of dialysis that can be done at home is peritoneal dialysis.

 

It is a less invasive form of dialysis than hemodialysis, and people with particular medical issues frequently prefer it. Newer and more effective dialysis equipment and consumables are being developed as a result of technological breakthroughs. For instance, the introduction of disposable dialyzers has improved the affordability and convenience of home dialysis for patients. The market is also being shaped by government dialysis treatment reimbursement regulations. Governments are increasingly focusing on home dialysis in many nations since it is more economical than in-center dialysis.

 

Hemodialysis and Peritoneal Dialysis Market Regional Analysis

North America: With over 40% of the global market share for hemodialysis and peritoneal dialysis in 2023, North America is the region with the largest market. The main factor influencing market growth is the high prevalence of end-stage renal disease (ESRD) and chronic kidney disease (CKD) in the area. The high levels of disposable income and the availability of reimbursement for dialysis services in North America are further significant factors.

 

Europe: Europe will be the second-largest market for hemodialysis and peritoneal dialysis globally. The main drivers of market expansion in Europe are the ageing population and the rising frequency of CKD and ESRD. A second factor driving the market expansion is the financial aid that dialysis patients are receiving from the governments of various European nations.

 

Asia-Pacific: Asia Pacific is the region with the fastest-growing hemodialysis and peritoneal dialysis markets. The main factors propelling market expansion are the high rates of diabetes and hypertension in the area. The expanding public awareness of dialysis procedures and government measures to enhance kidney care are further significant causes.

 

South America and Middle East & Africa: Latin America, the Middle East, and Africa are relatively smaller markets for hemodialysis and peritoneal dialysis. However, due to the rising incidence of CKD and ESRD as well as the expanding number of government programmes to promote renal care, both markets are predicted to have significant development during the projected period.

 

Hemodialysis and Peritoneal Dialysis Market Segment Analysis

By Type: With over 90% of the global market, hemodialysis is the most popular form of dialysis. Hemodialysis is a procedure done in a hospital or a dialysis facility where waste materials are removed from the patient's blood by pumping it through a dialyzer.

Although peritoneal dialysis is a less typical form of dialysis, it is gaining popularity. Utilising the patient's own peritoneum, or the lining of the abdomen, as a filter to remove waste from the blood, peritoneal dialysis can be done at home.

 

By Product: The market for hemodialysis and peritoneal dialysis is dominated by the devices segment. Dialysis apparatus, such as machines and dialyzers, are included in this section.

Bloodlines, catheters, and other supplies used for dialysis are included in the consumables sector.

Hospitals, clinics, and dialysis facilities all offer various services, including dialysis treatment.

 

By End-User: The market for hemodialysis and peritoneal dialysis is dominated by the hospital sector. This is so because hospitals or dialysis facilities execute the majority of the dialysis procedures.

As more and more dialysis providers create outpatient clinics, the market for clinics and dialysis facilities is expanding quickly.

As more patients choose to perform their procedures at home, this market is also expanding.

 

Hemodialysis and Peritoneal Dialysis Market

 

Hemodialysis and Peritoneal Dialysis Market Competitive Landscape

As businesses create new goods and technologies and broaden their geographic reach, the competitive environment in the hemodialysis and peritoneal dialysis market is continuously changing. For instance, home dialysis has been increasingly popular recently as patients and healthcare professionals look for more practical and adaptable treatment alternatives. The market for products and services for home dialysis has become more competitive as a result. The growing emphasis on value-based treatment is another significant development in the hemodialysis and peritoneal dialysis markets. Currently, payers and providers are searching for dialysis solutions that can raise patient outcomes while lowering costs. Manufacturers are under pressure as a result to create goods and services that are more effective and reasonably priced.

 

Dialife SA: Dialife offers the full spectrum of tools and supplies required for hemodialysis treatments, including dialyzers, dialysis machines, and the majority of other consumables.

 

Strict quality, safety, and performance criteria apply to Dialife products. All of the products are developed, produced, and regulated by Dialife using a quality management system that has been ISO- and CE-certified. The Company had a revenue of $5.1 Million in 2022.

 

Baxter International Inc.: Healthcare professionals may treat patients more effectively and efficiently at the hospital bedside, in the operating room, in critical care units, at home, and in the dialysis clinic thanks to our extensive product portfolio. In order to boost access to care, prevent issues before they become life-threatening, improve patient outcomes, and lower overall costs, we are working with our partners to develop new and better methods. The Company had a revenue of $ 15.1 billion in 2022.

 

Hemodialysis and Peritoneal Dialysis Market Scope Table

Hemodialysis and Peritoneal Dialysis Market

Market Size in 2023

USD 93.70 Bn.

Market Size in 2030

USD 154.45 Bn.

CAGR (2024-2030)

  7.4 %

Historic Data

2018-2022

Base Year

2023

Forecast Period

2024-2030

Segment Scope

By Type

  • Hemodialysis
  • Peritoneal Dialysis

By Product

  • Devices
  • Consumables
  • Services

By End-User

  • Hospital
  • Clinics and dialysis centers
  • Home use

Regional Scope

North America- United States, Canada, and Mexico

Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe

Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC

Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa

South America – Brazil, Argentina, Rest of South America

 

Hemodialysis and Peritoneal Dialysis Market Key Players

  1. Baxter International Inc.
  2. B. Braun Melsungen AG
  3. Isopure Corp.   
  4. Dialife SA
  5. Becton, Dickinson and Company (BD)
  6. Diaverum
  7. Cantel Medical Corporation
  8. Nipro Corporation
  9. Asahi Kasei Corporation
  10. Medtronic plc
  11. Fresenius Medical Care AG & Co. KGaA


Frequently Asked Questions

The key players of Hemodialysis and Peritoneal Dialysis Market are Becton, Dickinson and Company (BD), Diaverum, Cantel Medical Corporation, Nipro Corporation and Medtronic plc.

1.    Hemodialysis and Peritoneal Dialysis Market: Research Methodology 
2.    Hemodialysis and Peritoneal Dialysis Market: Executive Summary
3.    Hemodialysis and Peritoneal Dialysis Market: Competitive Landscape

3.1. SMR Competition Matrix
3.2. Competitive Landscape
3.3. Key Players Benchmarking
3.4. Market Structure
3.4.1.    Market Leaders 
3.4.2.    Market Followers
3.4.3.    Emerging Players

3.5. Consolidation of the Market
4.    Hemodialysis and Peritoneal Dialysis Market: Dynamics
4.1. Market Trends by Region
4.1.1.    North America
4.1.2.    Europe
4.1.3.    Asia Pacific
4.1.4.    Middle East and Africa
4.1.5.    South America

4.2. Market Drivers by Region
4.2.1.    North America
4.2.2.    Europe
4.2.3.    Asia Pacific
4.2.4.    Middle East and Africa
4.2.5.    South America

4.3. Market Restraints
4.4. Market Opportunities
4.5. Market Challenges
4.6. PORTER’s Five Forces Analysis
4.7. PESTLE Analysis
4.8. Value Chain Analysis
4.9. Regulatory Landscape by Region
4.9.1.    North America
4.9.2.    Europe
4.9.3.    Asia Pacific
4.9.4.    Middle East and Africa
4.9.5.    South America

5.    Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Segments (by Value USD and Volume Units)
5.1. Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Type (2023-2030)
5.1.1.    Hemodialysis
5.1.2.    Peritoneal Dialysis

5.2. Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Product (2023-2030)
5.2.1.    Devices
5.2.2.    Consumables
5.2.3.    Services

5.3. Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by End-User (2023-2030)
5.3.1.    Hospital
5.3.2.    Clinics and dialysis centers
5.3.3.    Home use

5.4. Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Region (2023-2030)
5.4.1.    North America
5.4.2.    Europe
5.4.3.    Asia Pacific
5.4.4.    Middle East and Africa
5.4.5.    South America

6.    North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast (by Value USD and Volume Units)
6.1. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Type (2023-2030)
6.1.1.    Hemodialysis
6.1.2.    Peritoneal Dialysis

6.2. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Product (2023-2030)
6.2.1.    Devices
6.2.2.    Consumables
6.2.3.    Services

6.3. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by End-User (2023-2030)
6.3.1.    Hospital
6.3.2.    Clinics and dialysis centers
6.3.3.    Home use

6.4. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Country (2023-2030)
6.4.1.    United States
6.4.2.    Canada
6.4.3.    Mexico

7.    Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast (by Value USD and Volume Units)
7.1. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Type (2023-2030)
7.1.1.    Hemodialysis
7.1.2.    Peritoneal Dialysis

7.2. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Product (2023-2030)
7.2.1.    Devices
7.2.2.    Consumables
7.2.3.    Services

7.3. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by End-User (2023-2030)
7.3.1.    Hospital
7.3.2.    Clinics and dialysis centers
7.3.3.    Home use

7.4. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Country (2023-2030)
7.4.1.    UK
7.4.2.    France
7.4.3.    Germany
7.4.4.    Italy
7.4.5.    Spain
7.4.6.    Sweden
7.4.7.    Austria
7.4.8.    Rest of Europe

8.    Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast (by Value USD and Volume Units)
8.1. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Type (2023-2030)
8.1.1.    Hemodialysis
8.1.2.    Peritoneal Dialysis

8.2. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Product (2023-2030)
8.2.1.    Devices
8.2.2.    Consumables
8.2.3.    Services

8.3. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by End-User (2023-2030)
8.3.1.    Hospital
8.3.2.    Clinics and dialysis centers
8.3.3.    Home use

8.4. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Country (2023-2030)
8.4.1.    China
8.4.2.    S Korea
8.4.3.    Japan
8.4.4.    India
8.4.5.    Australia
8.4.6.    Indonesia 
8.4.7.    Malaysia
8.4.8.    Vietnam
8.4.9.    Taiwan
8.4.10.    Bangladesh 
8.4.11.    Pakistan
8.4.12.    Rest of Asia Pacific

9.    Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast (by Value USD and Volume Units)
9.1. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Type (2023-2030)
9.1.1.    Hemodialysis
9.1.2.    Peritoneal Dialysis

9.2. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Product (2023-2030)
9.2.1.    Devices
9.2.2.    Consumables
9.2.3.    Services

9.3. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by End-User (2023-2030)
9.3.1.    Hospital
9.3.2.    Clinics and dialysis centers
9.3.3.    Home use

9.4. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Country (2023-2030)
9.4.1.    South Africa
9.4.2.    GCC
9.4.3.    Egypt
9.4.4.    Nigeria
9.4.5.    Rest of ME&A

10.    South America Hemodialysis and Peritoneal Dialysis Market Size and Forecast (by Value USD and Volume Units)
10.1. South America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Type (2023-2030)
10.1.1.    Hemodialysis
10.1.2.    Peritoneal Dialysis

10.2. South America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Product (2023-2030)
10.2.1.    Devices
10.2.2.    Consumables
10.2.3.    Services

10.3. South America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by End-User (2023-2030)
10.3.1.    Hospital
10.3.2.    Clinics and dialysis centers
10.3.3.    Home use

10.4. South America Hemodialysis and Peritoneal Dialysis Market Size and Forecast, by Country (2023-2030)
10.4.1.    Brazil
10.4.2.    Argentina
10.4.3.    Rest of South America

11.    Company Profile: Key players
11.1. Baxter International Inc.
11.1.1.    Company Overview
11.1.2.    Financial Overview
11.1.3.    Business Portfolio
11.1.4.    SWOT Analysis
11.1.5.    Business Strategy 
11.1.6.    Recent Developments

11.2. B. Braun Melsungen AG
11.3. Isopure Corp.    
11.4. Dialife SA
11.5. Becton, Dickinson and Company (BD)
11.6. Diaverum
11.7. Cantel Medical Corporation
11.8. Nipro Corporation
11.9. Asahi Kasei Corporation
11.10. Medtronic plc
11.11. Fresenius Medical Care AG & Co. KGaA
12.    Key Findings
13.    Industry Recommendation

Enquiry Before Buy


Request Sample PDF